-
+21 +1
FDA Approves First Nonprescription Daily Oral Contraceptive
Today, the U.S. Food and Drug Administration approved Opill (norgestrel) tablet for nonprescription use to prevent pregnancy— the first daily oral contraceptive approved for use in the U.S. without a prescription. Approval of this progestin-only oral contraceptive pill provides an option for consumers to purchase oral contraceptive medicine without a prescription at drug stores, convenience stores and grocery stores, as well as online.
-
+12 +1
What's behind the FDA's controversial strategy for evaluating new COVID boosters
Some scientists are alarmed that the agency plans to evaluate the next generation of boosters by reviewing mouse studies alone. Others say there's no time to waste waiting for human trials.
-
+20 +1
FDA authorizes Pfizer COVID-19 vaccine for children 5-11
The Food and Drug Administration has issued an emergency authorization for the use of the Pfizer-BioNTech COVID-19 vaccine in children ages 5 to 11. The FDA's authorization follows the recommendation of its independent advisory committee, which earlier this week voted nearly unanimously in favor of authorizing the vaccine. The committee of 18 voting members voted 17 to 0 in favor, with one abstention.
-
+15 +1
Receiving a Flu Shot and Covid Vaccine at the Same Time Is Safe, Study Finds
According to a clinical trial led by researchers at the University of Bristol, individuals can receive a flu shot and their second dose of a Covid-19 vaccine simultaneously, Carl Zimmer reports for the New York Times. The preliminary results were released as a pre-print study in The Lancet in September and have not yet been peer-reviewed.
-
+12 +1
Pfizer earned $3.5 billion on COVID-19 vaccine in first quarter
Pfizer's COVID-19 vaccine earned the company $3.5 billion in the first three months of this year, representing nearly a quarter of its total revenue, the company announced ahead of its earnings call Tuesday.
-
+19 +1
F.D.A. Clears Pfizer Vaccine, and Millions of Doses Will Be Shipped Right Away
The Food and Drug Administration authorized Pfizer’s Covid-19 vaccine for emergency use on Friday, clearing the way for millions of highly vulnerable people to begin receiving the vaccine within days. The authorization is a historic turning point in a pandemic that has taken more than 290,000 lives in the United States. With the decision, the United States becomes the sixth country — in addition to Britain, Bahrain, Canada, Saudi Arabia and Mexico — to clear the vaccine. Other authorizations, including by the European Union, are expected within weeks.
-
+16 +1
Ex-OANN Reporter Emily Miller Out as FDA Spokeswoman After Just 11 Days on the Job
Her ouster came after a week in which the FDA took heat for overstating the benefits of convalescent plasma as a treatment for the coronavirus.
-
+4 +1
FDA approves video game for treating ADHD in kids
The U.S. Food and Drug Administration has for the first time approved a video game for treating attention deficit hyperactivity disorder in children. The FDA said Monday the game built by Boston-based Akili Interactive Labs can improve attention function. The game, called EndeavorRx, requires a prescription and is designed for children ages 8 to 12 with certain symptoms of ADHD.
-
+10 +1
FDA Allows Easier Access To MDMA for PTSD Treatment
The U.S. government has battled with recreational drugs for a long time. However, over the last decade, they have begun to see the medical benefits of these drugs. They even have legalized a few of them. One that is still illegal is MDMA (also referred to as molly). It has typically been known as party drug, oftentimes done at a festival or club. This was until it began being tested on subjects with PTSD and depression.
-
+32 +1
FDA Approves AR Surgery Tool That Gives Surgeons 'X-ray Vision'
Augmented reality will soon be used to give surgeons a type of x-ray vision -- and the U.S. Food and Drug Administration (FDA) has just given it the green light. Augmedics' new Xvision Spine System lets surgeons visualize the 3D spinal anatomy of a patient while operating.
-
+10 +1
FDA approves first contact lens that slows myopia progression
MiSight, the first contact lens indicated to slow the progression of myopia in children ages 8 to 12 years, has been approved by the U.S. Food and Drug Administration, the agency announced Friday.
-
+10 +1
Trump administration "relentless" in push to keep pesticide linked to brain damage in children available , says scientist
Chlorpyrifos is a widely used chemical product used on a variety of crops such as soya beans, alfafa, citrus, almonds, cotton, grapes and walnuts.
-
+15 +1
First peanut allergy treatment gains backing from FDA advisory panel
Agency will now decide whether to allow sale of treatment
-
+26 +1
Impossible Foods gets FDA approval to sell fake meat in grocery stores
Fake meat is coming to a barbecue near you. Impossible Foods has been granted approval by the FDA to sell its plant-based meat in US grocery stores this fall, reported Bloomberg. After expressing some initial doubts, the agency formally ruled that soy leghemoglobin -- the additive in Impossible Burgers that gives it a meat-like flavor and makes it "bleed" -- is safe for consumers to eat. If no objections are raised, the FDA rule change becomes effective on September 4th.
-
+25 +1
The Cranberry Caucus Is Insanely Powerful
A new law is...crazy.
-
+1 +1
Former FDA Gottlieb Admits Pods Help Smokers Quit But Should Be Pulled From Market
Former FDA Commissioner Gottlieb admitted at a conference that even though adult smokers use pods to quit, the products should be pulled from the market due to teen vaping 'epidemic'.
-
+22 +1
Feds Announce They Will Stop Regulating the Number of Cherries in Cherry Pies
The FDA has been regulating the frozen cherry pie market since 1977.
-
+5 +1
Beyond Meat is going public. Meat alternatives are going mainstream.
Beyond Meat, the plant-based meat company, started publicly trading Thursday morning, and the stock more than doubled in value right out of the gate — it’s now trading at $60, when just last week the company was estimating it would start selling at $19 to $21.
-
+15 +1
FDA approves esketamine, first major depression drug in decades
The Food and Drug Administration on Tuesday approved esketamine, the first major depression treatment to hit the U.S. market in decades and a new option for patients who haven’t responded to existing therapies.
-
+33 +1
Beware of Buying Young People's Blood to Prevent Aging, FDA Says
Taking a young person’s plasma and infusing it into an older person to ward off aging -- a therapy that’s fascinated some of the biggest names in Silicon Valley -- has no proven clinical benefit, the Food and Drug Administration said.
Submit a link
Start a discussion